Related Articles
Cytotoxic drugs in combination with the CXCR4 antagonist AMD3100 as a potential treatment option for pediatric rhabdomyosarcoma
Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines
The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
MET/ERK2 pathway regulates the motility of human alveolar rhabdomyosarcoma cells